ffcd 1709-sirtci: selective internal radiation therapy xelox, bevacizumab and atezolizumab in mcrc
Published 2 years ago • 163 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
0:32
will atezolizumab and bevacizumab be the new soc in high-risk hcc?
-
2:51
sirflox: results of the phase iii trial in mcrc
-
3:07
selective internal radiation therapy (sirt) | capital health hospital
-
1:24
vasculab - facility showcase
-
1:30
gibbs: sirflox phase iii colorectal cancer trial results
-
3:37
dr david boshell - selective internal radiation therapy (sirt)
-
9:56
lecture – escrs 2016 / adi abulafia, md
-
1:22:55
ap valves 2016_live case session i
-
18:37
total arterial revascularisation results
-
13:06
managing t790-negative egfr-mutated nsclc
-
3:51
clinical guidelines and ehr
-
0:13
omnitest 3 control solution 2 x 3 5ml 9332768g
-
38:44
lecture 2: general aspect of laboratory diagnosis of covid-19
-
1:06
sealsafe - safe and documented biospecimen collection
-
1:41
philips intellispace portal : suite pulmonaire transversale
-
1:28:53
resetting hospital efficiencies
-
10:57
clinical laserthermia systems (cls) - biostock life science summit 2019
-
2:02
case 4: upfront osimertinib in metastatic egfr nsclc